Alissa Trzeciak

Alissa Trzeciak

Auto-generated profile, based on publicly available information

Alissa Trzeciak

Immunology Program, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, USA

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 April 2016 in Blood
Verified
Journal Article
Open access
PDF file
RFRyan Flynn
Ryan Flynn
KPKatelyn Paz
Katelyn Paz
JDJing Du
Jing Du
DRDawn K. Reichenbach
Dawn K. Reichenbach
PTPatricia A. Taylor
Patricia A. Taylor
BBBruce R. Blazar
Bruce R. Blazar
Key Points: The ROCK2 inhibitor, KD025, decreases chronic GVHD pathology in multiple murine models. KD025 inhibits STAT3 phosphorylation to decrease RORγt and Bcl6 expression in both murine and human cells.

15 May 2017 in The Journal of Immunology
Verified
Journal Article
Open access
PDF file
AZAlexandra Zanin-Zhorov
Alexandra Zanin-Zhorov
JWJonathan M. Weiss
Jonathan M. Weiss
ATAlissa Trzeciak
Alissa Trzeciak
WCWei Chen
Wei Chen
JZJingya Zhang
Jingya Zhang
SWSamuel D. Waksal
Samuel D. Waksal
Targeted inhibition of Rho-associated kinase (ROCK)2 downregulates the proinflammatory T cell response while increasing the regulatory arm of the immune response in animals models of autoimmunity and Th17-skewing human cell culture in vitro. In this study, we report that oral administration of a selective ROCK2 inhibitor, KD025, reduces psoriasis area and severity index scores by 50% from baseline in 46% of patients with psoriasis vulgaris, and it decreases epidermal thickness as well as T cell infiltration in the skin. We observed significant reductions of IL-17 and IL-23, but not IL-6 and TNF-α, whereas IL-10 levels were increased in peripheral blood of clinical responders after 12 wk of treatment with KD025. Collectively, these data demonstrate that an orally available selective ROCK2 inhibitor downregulates the Th17-driven autoimmune response and improved clinical symptoms in psoriatic patients via a defined molecular mechanism that involves concurrent modulation of cytokines without deleterious impact on the rest of the immune system.

19 July 2016 in Science Signaling
Verified
Journal Article
Closed access
PDF file
JWJonathan M. Weiss
Jonathan M. Weiss
WCWei Chen
Wei Chen
MNMelanie S. Nyuydzefe
Melanie S. Nyuydzefe
ATAlissa Trzeciak
Alissa Trzeciak
RFRyan Flynn
Ryan Flynn
AZAlexandra Zanin-Zhorov
Alexandra Zanin-Zhorov
Rho-associated kinase 2 (ROCK2) determines the balance between human T helper 17 (TH17) cells and regulatory T (Treg) cells. We investigated its role in the generation of T follicular helper (TFH) cells, which help to generate antibody-producing B cells under normal and autoimmune conditions. Inhibiting ROCK2 in normal human T cells or peripheral blood mononuclear cells from patients with active systemic lupus erythematosus (SLE) decreased the number and function of TFH cells induced by activation ex vivo. Moreover, inhibition of ROCK2 activity decreased the abundance of the transcriptional regulator Bcl6 (B cell lymphoma 6) and increased that of Blimp1 by reducing the binding of signal transducer and activator of transcription 3 (STAT3) and increasing that of STAT5 to the promoters of the genes Bcl6 and PRDM1, respectively. In the MRL/lpr murine model of SLE, oral administration of the selective ROCK2 inhibitor KD025 resulted in a twofold reduction in the numbers of TFH cells and antibody-producing plasma cells in the spleen, as well as a decrease in the size of splenic germinal centers, which are the sites of interaction between TFH cells and B cells. KD025-treated mice showed a substantial improvement in both histological and clinical scores compared to those of untreated mice and had reduced amounts of Bcl6 and phosphorylated STAT3, as well as increased STAT5 phosphorylation. Together, these data suggest that ROCK2 signaling plays a critical role in controlling the development of TFH cells induced by autoimmune conditions through reciprocal regulation of STAT3 and STAT5 activation.

29 February 2016 in Nature Communications
Verified
Journal Article
Open access
JLJiqiang Lin
Jiqiang Lin
LYLu Yang
Lu Yang
HSHernandez Moura Silva
Hernandez Moura Silva
ATAlissa Trzeciak
Alissa Trzeciak
YCYongwon Choi
Yongwon Choi
JLJuan J. Lafaille
Juan J. Lafaille
Regulatory T-cell (Treg) selection in the thymus is essential to prevent autoimmune diseases. Although important rules for Treg selection have been established, there is controversy regarding the degree of self-reactivity displayed by T-cell receptors expressed by Treg cells. In this study we have developed a model of autoimmune skin inflammation, to determine key parameters in the generation of skin-reactive Treg cells in the thymus (tTreg). tTreg development is predominantly AIRE dependent, with an AIRE-independent component. Without the knowledge of antigen recognized by skin-reactive Treg cells, we are able to enhance skin-specific tTreg cell generation using three approaches. First, we increase medullary thymic epithelial cells by using mice lacking osteoprotegerin or by adding TRANCE (RANKL, Tnfsf11). Second, we inject intrathymically peripheral dendritic cells from skin-draining sites. Finally, we inject skin tissue lysates intrathymically. These findings have implications for enhancing the generation of organ-specific Treg cells in autoimmune diseases.

1 December 2019 in The Journal of Immunology
Verified
Journal Article
Open access
PDF file
ATAlissa Trzeciak
Alissa Trzeciak
YLYelena V. Lerman
Yelena V. Lerman
TKTae-Hyoun Kim
Tae-Hyoun Kim
MKMa Rie Kim
Ma Rie Kim
NMNguyen Mai
Nguyen Mai
MKMinsoo Kim
Minsoo Kim
Severe sepsis, a systemic inflammatory response to infection, is an increasing cause of morbidity in intensive care units. During sepsis, the vasculature is profoundly altered, leading to release of microbial virulence factors and proinflammatory mediators to surrounding tissue, causing severe systemic inflammatory responses and hypoxic injury of multiple organs. To date, multiple studies have explored pathologic conditions in many vital organs, including lungs, liver, and kidneys. Although data suggest that sepsis is emerging as a key driver of chronic brain dysfunction, the immunological consequence of severe inflammatory responses in the brain remain poorly understood. In this study, we used C57BL/6 sepsis mouse models to establish a disease phenotype in which septic mice with various degrees of severity recover. In the early phases of sepsis, monocytes infiltrate the brain with significantly elevated proinflammatory cytokine levels. In recovered animals, monocytes return to vehicle levels, but the number of brain-resident microglia is significantly increased in the cortex, the majority of which remain activated. The increase in microglia number is mainly due to self-proliferation, which is completely abolished in CCR2 knockout mice. Collectively our data suggest that early monocyte infiltration causes permanent changes to microglia during sepsis, which may ultimately dictate the outcome of future infections and neuropathological diseases.

11 June 2025 in Nature
Verified
Journal Article
Open access
PDF file
ZWZhaoquan Wang
Zhaoquan Wang
ALAllie Lipshutz
Allie Lipshutz
CTCelia Martínez de la Torre
Celia Martínez de la Torre
ATAlissa J. Trzeciak
Alissa J. Trzeciak
ZLZong-Lin Liu
Zong-Lin Liu
JPJustin S. A. Perry
Justin S. A. Perry
Despite the success of fructose as a low-cost food additive, epidemiological evidence suggests that high fructose consumption during pregnancy or adolescence is associated with disrupted neurodevelopment1,2,3. An essential step in appropriate mammalian neurodevelopment is the phagocytic elimination of newly formed neurons by microglia, the resident professional phagocyte of the central nervous system4. Whether high fructose consumption in early life affects microglial phagocytosis and whether this directly affects neurodevelopment remains unknown. Here we show that offspring born to female mice fed a high-fructose diet and neonates exposed to high fructose exhibit decreased phagocytic activity in vivo. Notably, deletion of the high-affinity fructose transporter GLUT5 (also known as SLC2A5) in neonatal microglia completely reversed microglia phagocytic dysfunction, suggesting that high fructose directly affects neonatal development by suppressing microglial phagocytosis. Mechanistically, we found that high-fructose treatment of mouse and human microglia suppresses phagocytosis capacity, which is rescued in GLUT5-deficient microglia. Additionally, we found that high fructose drives significant GLUT5-dependent fructose uptake and catabolism to fructose 6-phosphate, rewiring microglial metabolism towards a hypo-phagocytic state in part by enforcing mitochondrial localization of the enzyme hexokinase 2. Mice exposed to high fructose as neonates develop anxiety-like behaviour as adolescents—an effect that is rescued in GLUT5-deficient mice. Our findings provide a mechanistic explanation for the epidemiological observation that high-fructose exposure during early life is associated with increased prevalence of adolescent anxiety disorders.